✦ LIBER ✦

A preliminary study of the comparative effects of olanzapine and risperidone on cognition in schizophrenia

✍ Scribed by Yang-Tae Kim; Byung-Jo Kang

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 59 KB
Volume: 19
Category: Article
ISSN: 0885-6222
DOI: 10.1002/hup.584

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The aim of this study was to compare the effects of olanzapine and risperidone on cognitive functions in patients with schizophrenia. The subjects were schizophrenic outpatients, all meeting DSM‐IV diagnostic criteria for schizophrenia and already treated with risperidone. In the experimental group (15), risperidone was changed to olanzapine to be administered for 8 weeks. Risperidone was maintained without a change in the daily dose in the control group (13). The assessment of clinical symptoms and cognitive functions in both groups was made at baseline and at 8 weeks. The experimental group relative to the control group showed significant improvement in five items such as immediate and delayed recall of verbal memory, verbal fluency, visual memory and total error of executive function. Although these data are preliminary, they could suggest the possibility of cognitive benefits from treatment with olanzapine relative to risperidone. These findings did not appear to be mediated by changes in clinical symptoms and side effects. Copyright © 2004 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Comparative effects of risperidone and o

Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder

✍ Philip D. Harvey; Judy A. Napolitano; Lian Mao; Georges Gharabawi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Abstract ## Objective To examine the effects of risperidone and olanzapine on cognitive functioning in elderly patients with schizophrenia or schizoaffective disorder. ## Method One hundred seventy‐six elderly inpatients and outpatients with schizophrenia or schizoaffective disorder were enro

A preliminary study of the comparative e

A preliminary study of the comparative effects of olanzapine and fluphenazine on cognition in schizophrenic patients

✍ Tajana Ljubin; Danijela Žakić Milas; Ninoslav Mimica; Vera Folnegović-Šmalc; Gor 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 2 views

Neurocognition and its influencing facto

Neurocognition and its influencing factors in the treatment of schizophrenia—effects of aripiprazole, olanzapine, quetiapine and risperidone

✍ M. Riedel; R. Schennach-Wolff; R. Musil; S. Dehning; A. Cerovecki; M. Opgen-Rhei 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views

## Abstract ## Background To examine influencing variables of neurocognition in patients with schizophrenia and to predict cognition during antipsychotic treatment. ## Methods Data were obtained from patients with an acute episode of schizophrenia participating in two double‐blind and one open l

Comparison between risperidone, olanzapi

Comparison between risperidone, olanzapine, and clozapine in the management of chronic schizophrenia: a naturalistic prospective 12-week observational study

✍ Rael D. Strous; Marina Kupchik; Suzana Roitman; Sima Schwartz; Noach Gonen; Robe 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

## Abstract Risperidone, olanzapine, and clozapine are three atypical antipsychotic medications commonly used in the management of chronic schizophrenia. While they offer advantages with regard to clinical efficacy and side‐effect profile, few studies have compared them in a naturalistic prospectiv

A pilot, open study on the treatment of

A pilot, open study on the treatment of refractory schizophrenia with risperidone and clozapine

✍ Roberto Cavallaro; Cristina Colombo; Enrico Smeraldi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 2 views

The aim of this report is to show the results of a pilot, open label treatment programme for resistant schizophrenia in which risperidone was used before clozapine. Thirteen DSM I11 R, drug resistant schizophrenics were treated with risperidone p.0. at doses up to 16 mg/day for three months. Clinica

A comparison of the efficacy and safety

A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration

✍ C. W. Ritchie; E. Chiu; S. Harrigan; S. Macfarlane; M. Mastwyk; G. Halliday; H. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

Background Following an earlier study in which elderly patients with schizophrenia had their typical antipsychotic medication changed to olanzapine or risperidone, the 61 patients were followed for up to a further six months to see if either treatment was superior in terms of efficacy or side effect